| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/07/2004 | US6828337 Bicyclic retinods containing ester or acid group; useful for treating emphysema |
| 12/07/2004 | US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis |
| 12/07/2004 | US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 12/07/2004 | US6828327 Macroheterocylic compounds useful as kinase inhibitors |
| 12/07/2004 | US6828323 Isoalloxazine derivatives to neutralize biological contaminants |
| 12/07/2004 | US6828320 Heterocyclic compounds |
| 12/07/2004 | US6828317 Bactericides; gramnegative, grampositive bacteria |
| 12/07/2004 | US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 12/07/2004 | US6827942 Composition and method of use |
| 12/07/2004 | US6827929 Scar treatment composition |
| 12/07/2004 | US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect |
| 12/02/2004 | WO2004104204A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 12/02/2004 | WO2004104003A1 Novel pyridopyrazines and use thereof as kinase modulators |
| 12/02/2004 | WO2004103992A1 2-aminoquinoline derivative |
| 12/02/2004 | WO2004103980A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| 12/02/2004 | WO2004103971A1 Cyclic aminophenyl sulfamate derivative |
| 12/02/2004 | WO2004103392A1 Method of treatment of systemic injury secondary to burns |
| 12/02/2004 | WO2004103383A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 12/02/2004 | WO2004103353A2 Topical treatment of sebum related skin conditions |
| 12/02/2004 | WO2004103332A1 Cosmetic preparations |
| 12/02/2004 | WO2004103331A1 Sun tanning products and products for treatment of the skin before and after exposure to the sun |
| 12/02/2004 | WO2004075849A3 Method and composition for treating hypopigmentation of the hair and skin |
| 12/02/2004 | WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1 |
| 12/02/2004 | WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 12/02/2004 | US20040242928 Reverse hydroxamic acid derivatives |
| 12/02/2004 | US20040242890 Agonists of beta-adrenoceptors |
| 12/02/2004 | US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents; |
| 12/02/2004 | US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis |
| 12/02/2004 | US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy |
| 12/02/2004 | US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 12/02/2004 | US20040242672 Pyrrolidine derivatives |
| 12/02/2004 | US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant |
| 12/02/2004 | US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 12/02/2004 | US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity |
| 12/02/2004 | US20040242612 Use of tyrosine kinase inhibitors for promoting hair growth |
| 12/02/2004 | US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 12/02/2004 | US20040242579 Protective coatings; drugs, cosmetics, veterinary medicine; a diaminotriazine compound |
| 12/02/2004 | US20040242574 Anticancer agents; antiarthritic agents |
| 12/02/2004 | US20040242544 Stabilized derivatives of ascorbic acid-3-phosphate |
| 12/02/2004 | US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin |
| 12/02/2004 | US20040242506 Formed from paroxetine hydrochloride and ammonium glycyrrhyzinate by precipitation, spray, vacuum or freeze drying, or evaporation to glass; solid or oil; masks the bitter taste of paroxetine and has a distinctive licorice flavor; antidepressants; Parkinson's disease |
| 12/02/2004 | US20040242499 For example, N-[2- beta -D-galactopyranosylthio-1-(tetradecylcarbamoyl)ethyl]octadecanoylamide or N-[2-( beta -D-galactopyranosyloxy)ethyl]octadecanoylamide; for treating rough skin |
| 12/02/2004 | US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 12/02/2004 | US20040242466 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 12/02/2004 | US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241286 Skin diet |
| 12/02/2004 | US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids |
| 12/02/2004 | US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents |
| 12/02/2004 | US20040241197 Creatinine and derivatives used as stabilizers for creatine and derivatives; treatment and prophylaxis of ultraviolet radiation and/or ozone-induced skin damage, inflammatory and degenerative skin conditions, of sensitive or dry skin, of skin aged in a natural way, of damage by photoaging; pruritus |
| 12/02/2004 | US20040241184 Fermentation product of cyptoporous volvatus and its preparation method and use |
| 12/02/2004 | US20040241149 prevention or prophylaxis of inflammatory condition comprising administering lactic acid bacteria containing unmethylated cytosine-guanine (cpg) dinucleotide to modulate the cytokine response of human or animal immune system; antiinflammatory agents |
| 12/02/2004 | DE202004009180U1 Formulation comprising glycine-containing gel, useful, by external or internal application, for treatment or prevention of e.g. allergy, sunburn and stress |
| 12/02/2004 | CA2557625A1 Method of treatment of systemic injury secondary to burns |
| 12/02/2004 | CA2526374A1 2-aminoquinoline derivatives |
| 12/02/2004 | CA2526349A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 12/02/2004 | CA2525945A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| 12/02/2004 | CA2525304A1 Recombinant gene medicine of adenovirus vector and gene p53 for treating proliferative diseases |
| 12/02/2004 | CA2524868A1 Topical treatment of skin conditions |
| 12/01/2004 | EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1481989A1 A-33 related antigens and their pharmacological uses |
| 12/01/2004 | EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 12/01/2004 | EP1481689A1 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth |
| 12/01/2004 | EP1481677A1 Cosmetic and/or dermatological composition containing ascorbic acid or its derivatives stabilised by at least one amphiphilic polymer chosen from oligomers or polymers derived from polyisobutylene |
| 12/01/2004 | EP1481250A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/01/2004 | EP1481077A2 Mitotic kinesin inhibitors |
| 12/01/2004 | EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 12/01/2004 | EP1480983A1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 12/01/2004 | EP1480981A1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives |
| 12/01/2004 | EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 12/01/2004 | EP1480964A1 Inhibiteurs de l'angiogenese |
| 12/01/2004 | EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 12/01/2004 | EP1480961A1 Glutaminyl based dpiv inhibitors |
| 12/01/2004 | EP1480959A1 Piperazine derivatives as anti-inflammatory agents |
| 12/01/2004 | EP1480957A1 Hppars activators |
| 12/01/2004 | EP1480954A1 Vanilloid receptor modulators |
| 12/01/2004 | EP1480936A2 Process for the preparation of acitretin |
| 12/01/2004 | EP1480736A2 Microcapsules having high carotenoid content |
| 12/01/2004 | EP1480654A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| 12/01/2004 | EP1480639A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 |
| 12/01/2004 | EP1480603A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations |
| 12/01/2004 | EP1480598A2 Manipulation of cytokine levels using cd83 gene products |
| 12/01/2004 | EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides |
| 12/01/2004 | EP1435787A4 Nestin-expressing hair follicle stem cells |
| 12/01/2004 | EP1263761B1 Compounds for pdt |
| 12/01/2004 | EP1261355B1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 12/01/2004 | EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway |
| 12/01/2004 | EP1173403B1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions |
| 12/01/2004 | EP1119538B1 Derivatives of phenantrene for medicinal use and a process for their preparation |
| 12/01/2004 | EP1059943B1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 12/01/2004 | EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 12/01/2004 | EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds |
| 12/01/2004 | EP0961610B1 Skin preparation |
| 12/01/2004 | CN1551919A 治疗性结合分子 Therapeutic binding molecules |
| 12/01/2004 | CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 12/01/2004 | CN1551877A Piperidine derivatives useful as CCR5 antagonists |
| 12/01/2004 | CN1551872A Biologically active methylene blue derivatives |